Timolol Maleate NDC 25021-009

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-009Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0009Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-009-05	25021000905	1 BOTTLE in 1 CARTON (25021-009-05) / 5 mL in 1 BOTTLEMarketed from Jan 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Timolol Maleate
Generic name (nonproprietary): timolol maleate
Active ingredients: Timolol maleate — 5 mg/mL
Dosage form: Solution, Gel forming / drops
Route: Ophthalmic
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214645
Marketing start: Jan 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 25021-009_ff0af07d-608a-44c6-936a-f22e726d3f41SPL ID ff0af07d-608a-44c6-936a-f22e726d3f41SPL set ID 272bb565-f099-4896-b2f6-48ab9180e941RxCUI 313407, 313408UNII P8Y54F701R
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425021000905 followed by a unit qualifier and the quantity

Package 25021-0009-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Timolol Maleate Ophthalmic Gel Forming Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214645

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214645
Product	Strength	Form · route	Labeler	Product NDC
timolol maleate ophthalmic gel forming solution	Timolol maleate 2.5 mg/mL	Solution, Gel forming / dropsOphthalmic	Gland Pharma Limited	68083-457
timolol maleate ophthalmic gel forming solutiontimolol maleate ophthalmic gel forming	Timolol maleate 5 mg/mL	Solution, Gel forming / dropsOphthalmic	Gland Pharma Limited	68083-458
Timolol Maleate	Timolol maleate 2.5 mg/mL	Solution, Gel forming / dropsOphthalmic	Sagent Pharmaceuticals	25021-008
Timolol Maleate Ophthalmic Gel Forming Solution	Timolol maleate 2.5 mg/mL	Solution, Gel forming / dropsOphthalmic	FOSUN PHARMA USA INC	72266-199
Timolol Maleate Ophthalmic Gel Forming Solution	Timolol maleate 5 mg/mL	Solution, Gel forming / dropsOphthalmic	FOSUN PHARMA USA INC	72266-200